174 related articles for article (PubMed ID: 36140308)
1. Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation.
Jorge J; Magalhães N; Alves R; Lapa B; Gonçalves AC; Sarmento-Ribeiro AB
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140308
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response.
Xie J; Lai Z; Zheng X; Liao H; Xian Y; Li Q; Wu J; Ip S; Xie Y; Chen J; Su Z; Lin Z; Yang X
Toxicology; 2021 Mar; 451():152680. PubMed ID: 33465425
[TBL] [Abstract][Full Text] [Related]
3. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
Jorge J; Neves J; Alves R; Geraldes C; Gonçalves AC; Sarmento-Ribeiro AB
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298119
[TBL] [Abstract][Full Text] [Related]
4. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
5. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc.
Mata-Greenwood E; Cuendet M; Sher D; Gustin D; Stock W; Pezzuto JM
Leukemia; 2002 Nov; 16(11):2275-84. PubMed ID: 12399973
[TBL] [Abstract][Full Text] [Related]
6. Brusatol, an NRF2 inhibitor for future cancer therapeutic.
Cai SJ; Liu Y; Han S; Yang C
Cell Biosci; 2019; 9():45. PubMed ID: 31183074
[TBL] [Abstract][Full Text] [Related]
7. Role of caspase-3-cleaved/activated PAK2 in brusatol-triggered apoptosis of human lung cancer A549 cells.
Huang CH; Wang FT; Chan WH
Toxicol Res (Camb); 2022 Oct; 11(5):791-803. PubMed ID: 36337251
[TBL] [Abstract][Full Text] [Related]
8. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.
Olayanju A; Copple IM; Bryan HK; Edge GT; Sison RL; Wong MW; Lai ZQ; Lin ZX; Dunn K; Sanderson CM; Alghanem AF; Cross MJ; Ellis EC; Ingelman-Sundberg M; Malik HZ; Kitteringham NR; Goldring CE; Park BK
Free Radic Biol Med; 2015 Jan; 78():202-12. PubMed ID: 25445704
[TBL] [Abstract][Full Text] [Related]
9. Antitumor agents. XXXV: Effects of brusatol, bruceoside A, and bruceantin on P-388 lymphocytic leukemia cell respiration.
Eigebaly SA; Hall IH; Lee KH; Sumida Y; Imakura Y; Wu RY
J Pharm Sci; 1979 Jul; 68(7):887-90. PubMed ID: 222889
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of baicalin from the Scutellaria baicalensis radix extract in B-acute lymphoblastic leukemia with different chromosomal rearrangements.
Orzechowska BU; Wróbel G; Turlej E; Jatczak B; Sochocka M; Chaber R
Int Immunopharmacol; 2020 Feb; 79():106114. PubMed ID: 31881375
[TBL] [Abstract][Full Text] [Related]
12. Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage.
Sun X; Wang Q; Wang Y; Du L; Xu C; Liu Q
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347930
[TBL] [Abstract][Full Text] [Related]
13. Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Liu Y; Lu Y; Celiku O; Li A; Wu Q; Zhou Y; Yang C
J Natl Cancer Inst; 2019 Oct; 111(10):1033-1041. PubMed ID: 30759236
[TBL] [Abstract][Full Text] [Related]
14. Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia.
Oh ET; Kim CW; Kim HG; Lee JS; Park HJ
Theranostics; 2017; 7(14):3415-3431. PubMed ID: 28912885
[TBL] [Abstract][Full Text] [Related]
15. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
17. Brusatol Protects HepG2 Cells against Oxygen-Glucose Deprivation-Induced Injury via Inhibiting Mitochondrial Reactive Oxygen Species-Induced Oxidative Stress.
Zhu S; Liu S; Wang L; Ding W; Sha J; Qian H; Lu Y
Pharmacology; 2020; 105(7-8):416-423. PubMed ID: 31825932
[TBL] [Abstract][Full Text] [Related]
18. Combination of ERK2 and STAT3 Inhibitors Promotes Anticancer Effects on Acute Lymphoblastic Leukemia Cells.
Jasek-Gajda E; Jurkowska H; JasiŃska M; Litwin JA; Lis GJ
Cancer Genomics Proteomics; 2020; 17(5):517-527. PubMed ID: 32859630
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H
Soto-Mercado V; Mendivil-Perez M; Jimenez-Del-Rio M; Fox JE; Velez-Pardo C
Leuk Res; 2020 Aug; 95():106389. PubMed ID: 32540572
[TBL] [Abstract][Full Text] [Related]
20. An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells.
Chandrasekaran J; Balasubramaniam J; Sellamuthu A; Ravi A
J Pharm Pharmacol; 2021 Apr; 73(6):749-757. PubMed ID: 33769483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
